Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Aspart vs Human Soluble Insulin in Chinese Diabetics
NCT00593255Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2004
- Primary completion
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jul 2004; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00593255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593255.